Fifty one jurisdictions were each researched on cannabis, hemp, psychedelics, broader drug policy, active legislation, and the politics around them, then read together for the patterns that only show up at scale. Companion to the per-state briefs and the comparison spreadsheet.
Looked at one state at a time, drug policy in 2026 reads as fifty one separate stories. Read together, it reads as one procedure running in parallel. The same moves recur across every region and both parties: a shared or lightly held thing is reframed as a problem, turned into a licensed and countable unit, titled to a small number of approved holders, and the older customary use is made an offense. That is the enclosure algorithm, and the national drug-policy map in 2026 is one of the clearest places to watch it run in real time.
On a one to five enclosure-pressure scale, where one is open and decentralized and five is heavily fenced, the average across all fifty one jurisdictions is 3.6. Thirty sit at four. Only three sit as low as two, and only two reach five. The center of gravity is consolidation.
If there is one finding the whole roundtable agrees on, it is this. The federal redefinition of hemp to a total-THC standard, taking full effect on November 12, 2026, appears in essentially every brief, in every region, under every party. It is the rare policy event that hits all fifty one jurisdictions at once, and it is the enclosure algorithm in miniature, performed nationally on a single schedule.
States are responding in two ways, and both are enclosure. The first is to route intoxicating hemp into the licensed cannabis system, so the only legal path runs through the capped, taxed, large-operator channel: California, Connecticut, Delaware, New Jersey, Nevada, Minnesota, and Washington all do versions of this. The second is to ban it outright: Arkansas, Georgia, Idaho, Tennessee, South Dakota, Wyoming, and others. Either way, a sprawling, low-barrier, often rural and small-business hemp economy is being closed, and the value is moving either to licensed cannabis incumbents or out of legality entirely. The states still running an open hemp market, like Wisconsin and North Carolina, are precisely the ones bracing for the biggest shock.
The most fenced jurisdictions in 2026 are Florida and Idaho, both scored five. Florida is a medical-only, vertically integrated, MSO-dominated market where the renewed adult-use amendment was kept off the 2026 ballot and every hemp restriction bill failed, leaving consolidation on both sides. Idaho is near-total prohibition, with a legislature actively trying to amend the constitution so voters can never legalize a drug by initiative.
The least fenced, scored two, are Alaska, Vermont, and Wyoming. And here is the trap. Alaska and Vermont are open in the meaningful sense: real legal markets with home grow, small-grower-friendly licensing, and residency rules that keep the large multistate operators out. Wyoming is open only in the sense that there is nothing to consolidate, because prohibition itself is the fence. A low score can mean a healthy commons or a locked gate with no market behind it, and the two should never be read as the same thing. This is worth holding onto, because the enclosers benefit when the only choices on offer look like corporate capture or prohibition, and the whole point of the commons argument is that there is a third option.
The most important pattern for the thesis is that enclosure does not stop when a commons is opened. It follows the opening in. The mature adult-use states are being fenced from within, by three tools.
Taxes. Michigan added a 24 percent wholesale tax effective January 2026 and is being sued over it. Washington carries the nation's highest cannabis excise at 37 percent. Maine raised its tax 40 percent. California, Maryland, Minnesota, Connecticut, and New Jersey have all raised rates. High taxes do not fall on everyone equally; they favor the capitalized incumbent who can absorb them and squeeze out the small operator who cannot.
Caps and moratoria. Oregon and Montana both froze new licenses, Montana explicitly under a law called Freeze the Footprint. New Mexico let saturation do the same work, shaking out roughly a third of operators. Caps protect the holders inside the fence.
The boldest case is Ohio. Voters legalized adult-use by statute in 2023. Because it was a statute and not a constitutional amendment, the legislature simply rewrote it through Senate Bill 56, capping dispensaries, killing the small-cultivator tier, and ending the social-equity program. That is enclosure of an already-open commons, performed by the legislature against the voters, and it is the single clearest example in the whole roundtable of the algorithm running in reverse against a win.
Nearly every state that promised social equity has watched capital fence it. Arizona lost almost all of its equity licenses to outside investors. Illinois litigated its slow rollout for years. New York's equity and CAURD licensees are squeezed by capital and real-estate pressure. The lesson repeats: a license set aside for the dispossessed, without protection against capital, becomes another asset for the people who already have capital. Equity without anti-capture design is just a slower enclosure.
A clean divide runs through the data. States with a citizen-initiative process, mostly in the West plus Ohio, Missouri, and a few others, tend to have won cannabis reform directly from the people, and then watched legislatures and courts try to claw it back. South Dakota voters passed adult-use and had it struck down. Idaho is trying to abolish the initiative route for drugs entirely. Nebraska voters passed medical cannabis and are still fighting to make it real. Ohio shows the clawback in full.
States without a citizen-initiative process, most of the South and much of the Northeast including New Jersey, New York, Connecticut, Virginia, Pennsylvania, Tennessee, and the Carolinas, can only move through their legislatures, where reform mostly stalls or passes in heavily fenced form. The initiative process is itself a commons, and the right to use it is itself being enclosed.
Psychedelics in 2026 look like cannabis fifteen years ago. Oregon and Colorado run live services programs, New Mexico became the third state to authorize therapeutic psilocybin, and Utah runs pilots. Behind them sit a row of research-only programs, including a 50 million dollar ibogaine effort in Texas and university studies in several states. The briefs already show the opening move of enclosure here: medicalization, standardization, and the question of who will own the approved formulation. This is exactly the window Del Potter's Open Formulation is built to get ahead of, and the state map shows why the timing matters.
Harm reduction splits sharply by region. The Northeast and West run syringe services, broad naloxone access, legal fentanyl test strips, and in Rhode Island, New York, and Vermont, sanctioned overdose prevention centers. Much of the South and Plains still classifies fentanyl test strips as paraphernalia, Texas and Indiana among them, and lacks authorized syringe services. Several briefs flag a new pressure: federal SAMHSA funding cuts in 2026 threatening even the programs that exist. The most basic commons of all, staying alive long enough to recover, is unevenly fenced by geography.
The value of doing all fifty one at once is that no single state could prove the claim, and together they do. The same procedure appears in red states and blue states, in prohibition states and legal states, in legislatures and at the ballot box, and on cannabis, hemp, and now psychedelics alike. It appears wherever the incentives and the inelastic-good economics predict it, and it is absent where they are not, which is the signature of a structural pattern rather than a coincidence or a conspiracy. The hemp cliff is the clearest single instance: one abstraction, written once in federal law, fencing a commons in every jurisdiction on the same day.
The counter-move is visible too, wherever people are allowed to run it: home grow rights, small-grower license tiers, residency rules that keep out the giants, automatic expungement, sanctioned harm-reduction sites, and the citizen-initiative process itself. Alaska and Vermont show that an open market is possible and durable. The work is to defend those openings before they are fenced, and to keep saying, out loud and state by state, that the choice was never only between corporate capture and prohibition.
Methodology: each jurisdiction was researched independently against 2025 and 2026 sources, written to a standardized brief, and read together here. The enclosure score is an editorial read, one to five, defined in the spreadsheet legend. Bill lists are thorough on significant measures and link live trackers for the long tail; sponsor names are given where confirmable and marked unconfirmed otherwise. A planning synthesis, not legal advice. Confirm any single detail against the per-state brief and the cited sources before acting on it.
This work is free and reader-funded. No paywalls, no ads. This brief is independent and fully sourced, and reader contributions are what keep the 50-state coverage current and answerable to readers, not advertisers or owners.
If it helped you, please chip in $5 to keep it going. Recurring support helps most; about $25 funds a full refresh of a state brief like this one.
A planning snapshot for 2026, not legal advice. Policy moves quickly; confirm any single detail against the cited sources before acting on it. Sponsor names are given where confirmable and marked unconfirmed otherwise.